These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14998635)

  • 41. Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
    Mosca L; Appel LJ; Benjamin EJ; Berra K; Chandra-Strobos N; Fabumni RP; Grady D; Haan CK; Hayes SN; Judelson DR; Keenan NL; McBride P; Oparil S; Ouyang P; Oz MC; Mendelsohn ME; Pasternak RC; Pinn VW; Robertson RM; Schenck-Gustafsson K; Sila CA; Smith SC; Sopko G; Taylor AL; Walsh BW; Wenger NK; Williams CL;
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):394-6. PubMed ID: 15003972
    [No Abstract]   [Full Text] [Related]  

  • 42. Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
    Mosca L; Appel LJ; Benjamin EJ; Berra K; Chandra-Strobos N; Fabunmi RP; Grady D; Haan CK; Hayes SN; Judelson DR; Keenan NL; McBride P; Oparil S; Ouyang P; Oz MC; Mendelsohn ME; Pasternak RC; Pinn VW; Robertson RM; Schenck-Gustafsson K; Sila CA; Smith SC; Sopko G; Taylor AL; Walsh BW; Wenger NK; Williams CL;
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):e29-50. PubMed ID: 15003974
    [No Abstract]   [Full Text] [Related]  

  • 43. [Guidelines, recommendations and positions].
    Hense HW
    Dtsch Med Wochenschr; 2000 Jul; 125(28-29):851. PubMed ID: 10943213
    [No Abstract]   [Full Text] [Related]  

  • 44. Limitations of current cardiovascular disease risk assessment strategies in women.
    Sibley C; Blumenthal RS; Merz CN; Mosca L
    J Womens Health (Larchmt); 2006; 15(1):54-6. PubMed ID: 16417419
    [No Abstract]   [Full Text] [Related]  

  • 45. Status of women in cardiovascular clinical trials.
    Kim ES; Menon V
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):279-83. PubMed ID: 19221204
    [No Abstract]   [Full Text] [Related]  

  • 46. Evidence-based guidelines for cardiovascular disease prevention in women.
    Mosca L; Appel LJ; Benjamin EJ; Berra K; Chandra-Strobos N; Fabunmi RP; Grady D; Haan CK; Hayes SN; Judelson DR; Keenan NL; McBride P; Oparil S; Ouyang P; Oz MC; Mendelsohn ME; Pasternak RC; Pinn VW; Robertson RM; Schenck-Gustafsson K; Sila CA; Smith SC; Sopko G; Taylor AL; Walsh BW; Wenger NK; Williams CL;
    Circulation; 2004 Feb; 109(5):672-93. PubMed ID: 14761900
    [No Abstract]   [Full Text] [Related]  

  • 47. Coronary heart disease in women: update 2008.
    Wenger NK; Shaw LJ; Vaccarino V
    Clin Pharmacol Ther; 2008 Jan; 83(1):37-51. PubMed ID: 18043680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Menopausal hormone therapy: currently no evidence for cardiac protection.
    Wenger NK
    Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Should the lack of feasibility of conducting controlled trials influence evidence-based guidelines?
    Kessler KM
    J Am Coll Cardiol; 2005 Mar; 45(5):810-1; author reply 811. PubMed ID: 15734635
    [No Abstract]   [Full Text] [Related]  

  • 50. Sexuality in women with cancer.
    Barton-Burke M; Gustason CJ
    Nurs Clin North Am; 2007 Dec; 42(4):531-54; vi. PubMed ID: 17996754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evidence based clinical aid for cardiovascular disease--what do GPs think?
    Mcavoy BR; Fulcher GR; Amerena JV; Conner GW; Beltrame JF; Hankey GJ; Keech AC; Lloyd BL; Neale ML; Pollock CA; Sudhir K; Waltham RD; West MJ;
    Aust Fam Physician; 2005 Apr; 34(4):297-8. PubMed ID: 15861759
    [No Abstract]   [Full Text] [Related]  

  • 52. The heart of women's health.
    Plate DS; Hughes S
    Am Fam Physician; 2006 Oct; 74(8):1285-6. PubMed ID: 17087423
    [No Abstract]   [Full Text] [Related]  

  • 53. Women's risk of heart disease: promoting awareness and prevention--a primary care approach.
    Schroetter SA; Peck SD
    Medsurg Nurs; 2008 Apr; 17(2):107-13. PubMed ID: 18517171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence-based practice to assist women in hospital settings to quit smoking and reduce cardiovascular disease risk.
    Buchanan L; Likness S
    J Cardiovasc Nurs; 2008; 23(5):397-406. PubMed ID: 18728512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 56. Reflections on the future of women's health research in a comparative context why more than sex and gender matters.
    Kazanjian A; Hankivsky O
    Womens Health Issues; 2008; 18(5):343-6. PubMed ID: 18723373
    [No Abstract]   [Full Text] [Related]  

  • 57. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The strengths and frailties of women with cardiovascular disease.
    Andreotti F; Modena MG
    Ital Heart J; 2003 Jun; 4(6):361-2. PubMed ID: 12898797
    [No Abstract]   [Full Text] [Related]  

  • 59. [Women and cardiovascular disease].
    Sluman MA; Verhaar MC; van der Wall EE; Westerveld HE
    Ned Tijdschr Geneeskd; 2006 Sep; 150(37):2018-22. PubMed ID: 17058457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fragile XX: the women's heart].
    Il Comitato Editoriale del Giornale Italiano di Cardiologia
    G Ital Cardiol (Rome); 2012 Jun; 13(6):379-80. PubMed ID: 22622113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.